Characterization of AAV-mediated dorsal root ganglionopathy-Reference-Cited by-同舟云学术

Characterization of AAV-mediated dorsal root ganglionopathy

Published:2022-03 Issue: Volume:24 Page:342-354
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Buss Nicholas^ORCID,Lanigan Lisa,Zeller Jillynne,Cissell Derek^ORCID,Metea Monica,Adams Eric,Higgins Mikayla,Kim Kwi Hye,Budzynski Ewa,Yang Lin,Liu Ye,Butt Mark,Danos Olivier,Fiscella Michele^ORCID

Funder

REGENXBIO

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference30 articles.

1. The clinical landscape for AAV gene therapies;Kuzmin;Nat. Rev. Drug Discov.,2021

2. Current clinical applications of in vivo gene therapy with AAVs;Mendell;Mol. Ther.,2021

3. Development challenges associated with rAAV-based gene therapies;Bolt;J. Toxicol. Sci.,2021

4. Adeno-associated virus-induced dorsal root ganglion pathology;Hordeaux;Hum. Gene Ther.,2020

5. Toxicology study of intra-cisterna magna adeno-associated virus 9 expressing human alpha-L-Iduronidase in Rhesus Macaques;Hordeaux;Mol. Ther. Methods Clin. Dev.,2018

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy clinical trials worldwide to 2023—an update;The Journal of Gene Medicine;2024-08

2. AAV6 mediated Gsx1 expression in neural stem progenitor cells promotes neurogenesis and restores locomotor function after contusion spinal cord injury;Neurotherapeutics;2024-07

3. Engineering viral vectors for acoustically targeted gene delivery;Nature Communications;2024-06-10

4. Widespread correction of brain pathology in feline alpha-mannosidosis by dose escalation of intracisternal AAV vector injection;Molecular Therapy - Methods & Clinical Development;2024-06

5. An innate immune response to adeno-associated virus genomes decreases cortical dendritic complexity and disrupts synaptic transmission;Molecular Therapy;2024-06